Long-term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post-treatment.
Symington E, Rangarajan S, Lester W, Madan B, Pierce GF, Raheja P, Robinson TM, Osmond D, Russell CB, Vettermann C, Agarwal SK, Li M, Wong WY, Laffan M.
Symington E, et al. Among authors: agarwal sk.
Haemophilia. 2024 Mar;30(2):320-330. doi: 10.1111/hae.14936. Epub 2024 Feb 5.
Haemophilia. 2024.
PMID: 38317480
Clinical Trial.